The future of GMP is being written, and the people shaping it are coming together to discuss it.
IPA's 11th Advanced GMP Workshop brings regulators and industry leaders into one conversation on what quality systems need to look like for the next decade.
October 8 to 9, 2026 | Virtual | Free registration
https://t.co/BdoJ8SeeLu
How does India Pharma Inc stay relevant in Global Pharma's new world order?
Our Secretary General @sjainind joins Dr T S Parmar (@idma_india ) in the inaugural episode of #PharmaFrontlines by @ExpPharma , in conversation with @Viveka_Roy Watch here.
IPA's 11th Advanced GMP virtual workshop returns this October bringing together global regulators and industry quality leaders for two days of discussion on where GMP is headed.
Theme: 'Raising the Standard: GMP Quality Systems for the Next Decade'
๐ 8โ9 October 2026
๐ป Virtual
Save the date. Registration details coming soon.
#11thEdition #AGMP2026 #PharmaQuality #GMP #IndianPharmaceuticalAlliance
125 years of Indian pharma. One of the worldโs largest digital archives built for any industry.
For over a century, generations of scientists, entrepreneurs and institutions have shaped an industry that transformed access to medicines, made a lasting contribution to global health and helped establish India as the Pharmacy of the World.
At the @IIMAhmedabad Healthcare Summit in Ahmedabad, Smt. @AnupriyaSPatel , Union Minister of State for Health & Family Welfare and Chemicals & Fertilisers, launched the India Pharma Archives, the first publicly accessible digital platform capturing 125 years of India's pharmaceutical journey.
Developed by IIM Ahmedabad Archives in collaboration with the Indian Pharmaceutical Alliance, the initiative brings together the breadth and depth of the industryโs history in one place. Also present were Smt. Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, and Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, along with industry leaders and academicians.
The archive traces Indiaโs pharmaceutical journey from its early beginnings to its emergence as a global pharmaceutical powerhouse, bringing together stories, milestones, people, companies, documents and historical resources.
At its heart are oral histories capturing the lived experiences of first-generation founders and pioneers stories that have never before been documented.
Conceived as a living archive, it will continue to grow, enabling future generations of scientists, entrepreneurs, and industry leaders to learn from and build on the people, ideas and milestones that shaped Indian pharma.
Explore. Discover. Share.
https://t.co/SeIFXOXQ7N
@sjainind@ChinmayTumbe@Pharmadept@MoHFW_INDIA@PastPerfectLive@SanghamitraSen@AjantaPharmaLtd@Alkem_Lab@AurobindoGlobal@Cadila_Pharma@Alembic_Pharma@Cipla_Global@drreddys@EmcurePharma@glenmarkpharma@LupinIndia@Pharma_Mankind@MicroLbsLtd@PiramalPharma@SunPharma_Live@TorrentPharmaIn@ZydusUniverse@MacleodsPharm@AbbottNews@pharma_natco@PanaceaBiotec@USVPeptides
Today marks the Foundation Day of the Indian Pharmaceutical Alliance (IPA). Since 1999, our journey has been guided by one principle: improving access to medicines globally, anchored in three pillars: Quality, Innovation, and Global Reach.
India is regarded as the 'Pharmacy of the World', supplying quality-assured, affordable medicines to over 200 countries. IPA remains committed to make India the "Global Champion of Affordable Innovative Medicines" by 2047, in line with the inspiring ambition set by our Hon'ble Prime Minister Shri Narendra Modi ji for Indian pharma to rank among the Top 5 globally.
#IPAFoundationDay #HealthcareLeadership #IndianPharma #InnovationInPharma #GlobalHealth #MakeInIndia
@sjainind
Prime Minister @narendramodi Calls for Indian Pharma Companies to Make Mark Among Worldโs Top Five
โช๏ธโIndian Brands Should Become the Identity of Our Country and a Destination for the Worldโ -ย PM Narendra Modi
โช๏ธPrime Minister highlighted the significant work accomplished in the pharmaceutical sector and called for greater global ambition
Read here: https://t.co/Q2ZDUTjSsd
@dcpcindia #IndependenceDay2026 #IndiaAt80 #IndiaIndependenceDay
For decades, the world has turned to India when it needed medicine it could actually afford. From essential generics to life-saving vaccines, Indian pharma quietly became the world's safety net, trusted, reliable, and relentless in its purpose. 60%+ of global vaccine demand met by India
Largest number of USFDA-approved plants outside the US
Trusted supplier to 200+ nations
This Independence Day, we honour the scientists and manufacturers who built that trust and are now writing the next chapter in innovation.
Wishing everyone a proud Independence Day.
#IndependenceDay #PharmacyOfTheWorld #AtmanirbharBharat #MakeInIndia #IndianPharma #VaccinesForAll #GlobalHealth #TrustedByTheWorld #IndiaInnovates #HealthForAll
True independence is marked by continuous evolution. In a recent conversation with The Economic Times, @sjainind , our Secretary General, highlighted how India's healthcare legacy is transitioning from unmatched scale to pioneering R&D.
We are no longer just manufacturing medicines for the world; we are actively engineering the cures of tomorrow. ๐ฎ๐ณ
Click the link to read the full article.
https://t.co/ykunyHoXn5
#IndianPharma #Innovation #DrugDiscovery #MakeInIndia #IPA #HealthcareLeadership
From generics to novel therapies: India's next chapter in life sciences is taking shape
At TPCI's India IP Advantage Summit 2026, Archana Jatkar, Associate Secretary General, Indian Pharmaceutical Alliance, joined the discussion on "From Research to Market: Building India's Life Sciences IP Advantage" to talk about the opportunities and challenges shaping India's life sciences sector.
The conversation looked at what it will take for Indian pharma to build on its strength as the world's pharmacy and move further into complex generics, biosimilars, and novel therapies, along with the policy and IP reforms needed to support greater innovation, R&D, and investment in the sector.
As India builds on its role as the Pharmacy of the World to become a global life sciences innovation hub, this is exactly the kind of dialogue that will shape the path forward.
#IndiaIPAdvantageSummit2026 #IntellectualProperty #IndianPharma #IPA #LifeSciences
@TPCI_@sjainind
At the inaugural Global Drug Regulatory Conclave (GDRC) 2026, @sjainind, Secretary General, IPA, joined regulators, policymakers, industry leaders, and experts to discuss the evolving regulatory landscape and its role in strengthening healthcare delivery.
The conclave offered a platform for dialogue on regulatory priorities, emerging challenges, and opportunities for collaboration across the healthcare ecosystem.
#GDRC2026 #HealthcarePolicy #IndianPharma #IPA
Held a productive interaction with the delegation of the Indian Pharmaceutical Alliance (IPA), led by its President, Dr. Sharvil Patel.
Discussed opportunities to further strengthen Indiaโs pharma innovation ecosystem by attracting greater investments through enhanced R&D, clinical research, advanced therapeutics & greater industry-government collaboration.
Reiterated the Modi Governmentโs commitment to fostering a globally competitive & innovation-driven pharmaceutical sector while ensuring affordable healthcare.
@IPAOfficialPage
IPA ร ISRO: Exploring the Next Frontier in Pharmaceutical Innovation
The Indian Pharmaceutical Alliance (IPA) was proud to participate in the National Workshop on Microgravity Research, hosted by ISRO at its headquarters in Bengaluru. The workshop, which marked one year of India's landmark International Space Station mission, was inaugurated by Dr. V. Narayanan, Chairman, ISRO and Secretary, Department of Space, and brought together Group Captain Shubhanshu Shukla, policymakers, scientists, academia and industry leaders to explore how microgravity research can drive scientific advancement and economic value for the nation.
Speaking at the workshop, Sudarshan Jain, Secretary General, IPA, said: "The Indian Pharmaceutical Alliance will be keen to collaborate with ISRO to utilise space-based platforms for pharmaceutical research. Space research is a strategic area for the nation with significant future opportunities."
Shridhar Narayanan, Senior Advisor (Innovation), IPA, added: "Microgravity research has the potential to accelerate breakthroughs in areas such as protein crystallisation, advanced drug delivery and next-generation biologics. By bringing together the strengths of ISRO, research institutions and the pharmaceutical industry, we can build an ecosystem that drives innovation, strengthens India's scientific leadership and delivers better health outcomes for the world."
As India's pharmaceutical sector evolves from manufacturing excellence to innovation leadership, collaborations between the space and life sciences ecosystems can unlock transformative opportunities, shaping the future of healthcare.
@sjainind | @isro | @AbbottNews | @AjantaPharmaLtd | @Alkem_Lab | @Alembic_Pharma | @AurobindoGlobal | @Cadila_Pharma | @Cipla_Global | @drreddys | @EmcurePharma | Glenmark | Intas | Ipca Laboratories | @LupinGlobal | Macleods Pharma | @Pharma_Mankind | Micro Labs Limited | @pharma_natco | @PanaceaBiotec | @PiramalPharma | @SunPharma_Live | @TorrentPharmaIn | USV Limited | @ZydusUniverse
#ISRO #Microgravity #PharmaInnovation #LifeSciences #HealthcareInnovation #Research #Innovation #SpaceTech
Every day, viral hepatitis claims more than 3,500 lives worldwide, even though effective vaccines, treatments and, in the case of Hepatitis C, a cure exist.
The challenge is not a lack of science. It is ensuring that people are diagnosed early and have access to timely, quality care.
India is addressing this through Universal Hepatitis B immunisation, the National Viral Hepatitis Control Program, and expanded access to affordable, quality-assured medicines.
As the voice of India's research-driven pharmaceutical industry, IPA is committed to advancing affordable innovation and increasing access to quality medicines. Because innovation can only transform lives when it reaches the patients who need it most.
Source: World Health Organization, Global Hepatitis Report 2024 (2022 estimates).
#WorldHepatitisDay #IndianPharma #IPA #Vaccination #PublicHealth